News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Provalis Plc Announces Placing; Provalis Raises GBP2.6 Million To Help Support US Demand For In2it



10/19/2005 5:11:24 PM

Provalis plc ("Provalis" or "the Company") (LSE:PRO) (Nasdaq:PVLS), the Medical Diagnostics and Pharmaceuticals Group, has today raised GBP2.6 million (before expenses of GBP0.1 million) through a placing for cash of 33,066,000 new ordinary shares of 1 pence each (" New Ordinary Shares"), predominantly with institutional investors and at a placing price of 8p ("the Placing"). The Placing was undertaken to provide additional working capital for the Group to help satisfy the exceptional and unexpectedly high demand from US customers for its new "point of care" diabetes diagnostic product in2it(TM) A1c.

Read at Prime Zone


comments powered by Disqus
Provalis
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES